Predictors of Autosomal Dominant Polycystic Kidney Disease Progression

被引:127
作者
Schrier, Robert W. [1 ]
Brosnahan, Godela [1 ]
Cadnapaphornchai, Melissa A. [1 ]
Chonchol, Michel [1 ]
Friend, Keith [2 ]
Gitomer, Berenice [1 ]
Rossettit, Sandro [2 ]
机构
[1] Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA
[2] Otsuka Amer Pharmaceut Inc, Med Affairs, Cardiorenal Dept, Princeton, NJ USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 25卷 / 11期
关键词
LEFT-VENTRICULAR MASS; MAGNETIC-RESONANCE MEASUREMENTS; AMBULATORY BLOOD-PRESSURE; SERUM URIC-ACID; RENAL-FUNCTION; ENDOTHELIAL DYSFUNCTION; HYPERTENSIVE PATIENTS; NORMOTENSIVE PATIENTS; DIASTOLIC FUNCTION; MISSENSE MUTATION;
D O I
10.1681/ASN.2013111184
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Autosomal dominant polycystic kidney disease is a genetic disorder associated with substantial variability in its natural course within and between affected families. Understanding predictors for rapid progression of this disease has become increasingly important with the emergence of potential new treatments. This systematic review of the literature since 1988 evaluates factors that may predict and/or effect autosomal dominant polycystic kidney disease progression. Predicting factors associated with early adverse structural and/or functional outcomes are considered. These factors include PKD1 mutation (particularly truncating mutation), men, early onset of hypertension, early and frequent gross hematuria, and among women, three or more pregnancies. Increases in total kidney volume and decreases in GFR and renal blood flow greater than expected for a given age also signify rapid disease progression. Concerning laboratory markers include overt proteinuria, macroalbuminuria, and perhaps, elevated serum copeptin levels in affected adults. These factors and others may help to identify patients with autosomal dominant polycystic kidney disease who are most likely to benefit from early intervention with novel treatments.
引用
收藏
页码:2399 / 2418
页数:20
相关论文
共 109 条
  • [71] Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease
    Pérez-Oller, L
    Torra, R
    Badenas, C
    Milà, M
    Darnell, A
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (02) : 273 - 278
  • [72] Cardiac Magnetic Resonance Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease
    Perrone, Ronald D.
    Abebe, Kaleab Z.
    Schrier, Robert W.
    Chapman, Arlene B.
    Torres, Vicente E.
    Bost, James
    Kaya, Diana
    Miskulin, Dana C.
    Steinman, Theodore I.
    Braun, William
    Winklhofer, Franz T.
    Hogan, Marie C.
    Rahbari-Oskoui, Frederic
    Kelleher, Cass
    Masoumi, Amirali
    Glockner, James
    Halin, Neil J.
    Martin, Diego
    Remer, Erick
    Patel, Nayana
    Pedrosa, Ivan
    Wetzel, Louis H.
    Thompson, Paul A.
    Miller, J. Philip
    Meyers, Catherine M.
    Bae, K. Ty
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (10): : 2508 - 2515
  • [73] Influence of ACE (I/D) and G460W polymorphism of α-adducin in autosomal dominant polycystic kidney disease
    Persu, A
    El-Khattabi, O
    Messiaen, T
    Pirson, Y
    Chauveau, D
    Devuyst, O
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) : 2032 - 2038
  • [74] Modifier effect of ENOS in autosomal dominant polycystic kidney disease
    Persu, A
    Stoenoiu, MS
    Messiaen, T
    Davila, S
    Robino, C
    El-Khattabi, O
    Mourad, M
    Horie, S
    Feron, O
    Balligand, JL
    Wattiez, R
    Pirson, Y
    Chauveau, D
    Lens, XM
    Devuyst, O
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (03) : 229 - 241
  • [75] Cutaneous Microcirculation Is Impaired in Early Autosomal Dominant Polycystic Kidney Disease
    Ramunni, Alfonso
    Brescia, Paola
    Quaranta, Domenico
    Bianco, Maria Stella
    Ranieri, Prudenza
    Dolce, Ernesta
    Coratelli, Pasquale
    [J]. NEPHRON CLINICAL PRACTICE, 2009, 113 (02): : C71 - C75
  • [76] Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease
    Reed, Berenice Y.
    Masoumi, Amirali
    Elhassan, Elwaleed
    McFann, Kim
    Cadnapaphornchai, Melissa A.
    Maahs, David M.
    Snell-Bergeon, Janet K.
    Schrier, Robert W.
    [J]. KIDNEY INTERNATIONAL, 2011, 79 (01) : 128 - 134
  • [77] Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele
    Reiterova, Jana
    Stekrova, Jitka
    Merta, Miroslav
    Kotlas, Jaroslav
    Elisakova, Veronika
    Lnenicka, Petr
    Korabecna, Marie
    Kohoutova, Milada
    Tesar, Vladimir
    [J]. BMC NEPHROLOGY, 2013, 14
  • [78] Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype
    Rossetti, S
    Chauveau, D
    Kubly, V
    Slezak, JM
    Saggar-Malik, AK
    Pei, Y
    Ong, ACM
    Stewart, F
    Watson, ML
    Bergstralh, EJ
    Winearls, CG
    Torres, VE
    Harris, PC
    [J]. LANCET, 2003, 361 (9376) : 2196 - 2201
  • [79] Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease
    Rossetti, Sandro
    Kubly, Vickie J.
    Consugar, Mark B.
    Hopp, Katharina
    Roy, Sushmita
    Horsley, Sharon W.
    Chauveau, Dominique
    Rees, Lesley
    Barratt, T. Martin
    Van't Hoff, William G.
    Niaudet, W. Patrick
    Torres, Vicente E.
    Harris, Peter C.
    [J]. KIDNEY INTERNATIONAL, 2009, 75 (08) : 848 - 855
  • [80] Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: Results of a seven-year prospective randomized study
    Schrier, R
    McFann, K
    Johnson, A
    Chapman, A
    Edelstein, C
    Brosnahan, G
    Ecder, T
    Tison, L
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (07): : 1733 - 1739